查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1308904

栓塞治疗市场：按产品、适应症、手术和最终用户 - 2023-2030 年全球预测

Embolotherapy Market by Product, Disease Indication, Procedure, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年全球栓塞治疗市场将大幅成长，达到44.0494亿美元，年复合成长率为8.89%，2030年将达到80.0624亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球栓塞治疗市场至关重要。透过检验业务策略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发地区、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1.全球栓塞治疗市场规模及预测为何？

2.在预测期内，COVID-19 对全球栓塞治疗市场的阻碍因素和影响为何？

3.在预测期内，全球栓塞治疗市场需要投资哪些产品/细分市场/用途/领域？

4.全球栓塞治疗市场的竞争策略是什么？

5. 全球栓塞治疗市场的技术趋势和法律规范是什么？

6.全球栓塞治疗市场主要供应商的市占率为何？

7. 哪些型态和策略性措施被认为适合进入全球栓塞治疗市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 目标患者数量增加
      • 政府和民间组织的投资金筹措
      • 微创手术的有利报销方案
    • 抑制因素
      • 缺乏足够的证据和不利的法规情况
    • 机会
      • 新兴市场的成长机会
      • 扩大栓塞装置的用途
    • 任务
      • 缺乏熟练的外科医生
      • 新兴国家的栓塞治疗高成本且因此造成困难
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户客製化

第6章栓塞治疗市场：副产品

  • 介绍
  • 栓塞剂
    • 可拆卸气球
    • 栓塞圈
    • 栓塞系统
    • 液态栓塞剂
    • 微球
  • 支撑装置
    • 导丝
    • 微导管

第7章栓塞治疗市场：依适应症分类

  • 介绍
  • 癌症
  • 胃肠道疾病
  • 神经系统疾病
  • 週边血管疾病
  • 泌尿系统和肾臟疾病

第8章栓塞治疗市场：依程序

  • 介绍
  • 经动脉栓塞
  • 经导管动脉栓塞
  • 经导管动脉放射栓塞及选择性体内放射治疗

第9章栓塞治疗市场：依最终使用者分类

  • 介绍
  • 门诊手术中心
  • 医院和诊所

第10章美洲栓塞治疗市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第11章亚太栓塞治疗市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第12章欧洲、中东和非洲栓塞治疗市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第13章竞争形势

  • FPNV定位矩阵
  • 市占率分析：主要企业
  • 竞争情境分析：主要企业

第14章上市公司名单

第15章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-4308E1C88797

The Global Embolotherapy Market is forecasted to grow significantly, with a projected USD 4,404.94 million in 2023 at a CAGR of 8.89% and expected to reach a staggering USD 8,006.24 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Embolotherapy Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Embolotherapy Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Embolic Agents and Support Devices. The Embolic Agents is further studied across Detachable Balloons, Embolic Coils, Embolic Plug Systems, Liquid Embolic Agents, and Microspheres. The Support Devices is further studied across Guidewires and Microcatheters. The Embolic Agents is projected to witness significant market share during forecast period.

Based on Disease Indication, market is studied across Cancer, Gastrointestinal Disorders, Neurological Diseases, Peripheral Vascular Disease, and Urological & Nephrological Disorders. The Peripheral Vascular Disease is projected to witness significant market share during forecast period.

Based on Procedure, market is studied across Transarterial Chemoembolization, Transcatheter Arterial Embolization, and Transcatheter Arterial Radioembolization & Selective Internal Radiation Therapy. The Transcatheter Arterial Embolization is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Ambulatory Surgery Centers and Hospitals & Clinics. The Hospitals & Clinics is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Embolotherapy Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Embolotherapy Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Embolotherapy Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Embolotherapy Market?

4. What is the competitive strategic window for opportunities in the Global Embolotherapy Market?

5. What are the technology trends and regulatory frameworks in the Global Embolotherapy Market?

6. What is the market share of the leading vendors in the Global Embolotherapy Market?

7. What modes and strategic moves are considered suitable for entering the Global Embolotherapy Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Embolotherapy Market, by Product, 2022 vs 2030
  • 4.3. Embolotherapy Market, by Disease Indication, 2022 vs 2030
  • 4.4. Embolotherapy Market, by Procedure, 2022 vs 2030
  • 4.5. Embolotherapy Market, by End-User, 2022 vs 2030
  • 4.6. Embolotherapy Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing target patient population
      • 5.1.1.2. Investment & funding by government and private organizations
      • 5.1.1.3. Favorable reimbursement scenario for minimally invasive surgeries
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of sufficient evidence & unfavorable regulatory scenario
    • 5.1.3. Opportunities
      • 5.1.3.1. Growth opportunities in emerging markets
      • 5.1.3.2. Expanding applications of embolization devices
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of skilled surgeons
      • 5.1.4.2. High cost and resulting difficulties in accessing embolization in developing countries
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Embolotherapy Market, by Product

  • 6.1. Introduction
  • 6.2. Embolic Agents
    • 6.2.1. Detachable Balloons
    • 6.2.2. Embolic Coils
    • 6.2.3. Embolic Plug Systems
    • 6.2.4. Liquid Embolic Agents
    • 6.2.5. Microspheres
  • 6.3. Support Devices
    • 6.3.1. Guidewires
    • 6.3.2. Microcatheters

7. Embolotherapy Market, by Disease Indication

  • 7.1. Introduction
  • 7.2. Cancer
  • 7.3. Gastrointestinal Disorders
  • 7.4. Neurological Diseases
  • 7.5. Peripheral Vascular Disease
  • 7.6. Urological & Nephrological Disorders

8. Embolotherapy Market, by Procedure

  • 8.1. Introduction
  • 8.2. Transarterial Chemoembolization
  • 8.3. Transcatheter Arterial Embolization
  • 8.4. Transcatheter Arterial Radioembolization & Selective Internal Radiation Therapy

9. Embolotherapy Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgery Centers
  • 9.3. Hospitals & Clinics

10. Americas Embolotherapy Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Embolotherapy Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Embolotherapy Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. EMBOLOTHERAPY MARKET RESEARCH PROCESS
  • FIGURE 2. EMBOLOTHERAPY MARKET SIZE, 2022 VS 2030
  • FIGURE 3. EMBOLOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2022 VS 2030 (%)
  • FIGURE 6. EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2022 VS 2030 (%)
  • FIGURE 7. EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 8. EMBOLOTHERAPY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 9. EMBOLOTHERAPY MARKET DYNAMICS
  • FIGURE 10. EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. EMBOLOTHERAPY MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 19. EMBOLOTHERAPY MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. EMBOLOTHERAPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. EMBOLOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 6. EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. EMBOLOTHERAPY MARKET SIZE, BY DETACHABLE BALLOONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC COILS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC PLUG SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. EMBOLOTHERAPY MARKET SIZE, BY MICROSPHERES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 13. EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. EMBOLOTHERAPY MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. EMBOLOTHERAPY MARKET SIZE, BY MICROCATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 17. EMBOLOTHERAPY MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. EMBOLOTHERAPY MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. EMBOLOTHERAPY MARKET SIZE, BY NEUROLOGICAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. EMBOLOTHERAPY MARKET SIZE, BY UROLOGICAL & NEPHROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 23. EMBOLOTHERAPY MARKET SIZE, BY TRANSARTERIAL CHEMOEMBOLIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. EMBOLOTHERAPY MARKET SIZE, BY TRANSCATHETER ARTERIAL EMBOLIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. EMBOLOTHERAPY MARKET SIZE, BY TRANSCATHETER ARTERIAL RADIOEMBOLIZATION & SELECTIVE INTERNAL RADIATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. EMBOLOTHERAPY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. EMBOLOTHERAPY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. PHILIPPINES EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. SINGAPORE EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH KOREA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. TAIWAN EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. THAILAND EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. VIETNAM EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. DENMARK EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. EGYPT EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. FINLAND EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. FRANCE EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. GERMANY EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. ISRAEL EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. ITALY EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. NORWAY EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. POLAND EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 219. QATAR EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 243. SPAIN EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 249. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 261. TURKEY EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 279. EMBOLOTHERAPY MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 280. EMBOLOTHERAPY MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 281. EMBOLOTHERAPY MARKET LICENSE & PRICING